Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after

Claudia Pösel1, Johanna Scheibe2, Alexander Kranz2

  • 1From the Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany (C.P., J.S., A.K., E.Q., W.F., F.L., J.B., D.-C.W.); Translational Centre for Regenerative Medicine, Leipzig, Germany (A.K., V.B., E.Q., W.F., J.B., D.-C.W.); EVK Bielefeld, Bethel, Neurologische Klinik, Bielefeld, Germany (W.-R.S.); Department of Neurology, University of Münster, Germany (J.M.); and Massachusetts General Hospital and Harvard Medical School, Boston (J.B.). claudia.poesel@izi.fraunhofer.de.

Stroke
|July 3, 2014
PubMed